Biotech Archives - Page 661 of 733

1 minute read

Avalon Globocare Has Received A Notice Of Allowance For Its U.S. Patent Application 17/210,837 Titled “Qty Fc Fusion Water Soluble Receptor Proteins (For The Treatment Of Cytokine Release Syndrome)”

September 12, 11:32 AM

https://twitter.com/PatentGrants/status/1569347853348388864 https://patentcenter.uspto.gov/applications/17210837/ifw/docs

AVCO

1 minute read

AnaptysBio Sells Royalty Interest In Cancer Drug For $45M

By Vandana Singh

September 12, 11:18 AM

AnaptysBio Inc (NASDAQ:ANAB), a clinical-stage biotechnology company focused on immunology therapeutics, has sold its royalty interest on future global…

ANAB

1 minute read

Europe Approves Novavax’s COVID-19 Vaccine Booster For Adults

By Vandana Singh

September 12, 11:16 AM

The European Commission has approved the expanded conditional approval of Novavax Inc’s (NASDAQ:NVAX) Nuvaxovid COVID-19 vaccine as a homologous and heterologous booster…

NVAX

1 minute read

Regulus Shares Surge After Early-Stage RGLS8429 Data In Rare Kidney Disease

By Vandana Singh

September 12, 11:14 AM

Biopharmaceutical company Regulus Therapeutics Inc (NASDAQ: RGLS) shares jumped after topline safety and Pharmacokinetic (PK) data from its Phase 1 single-ascending dose (SAD) trial of RGLS8429 in autosomal dominant polycystic kidney disease (ADPKD).

RGLS

1 minute read

Novartis’ Cosentyx Shows To Ease Symptoms In Painful Skin Condition

By Vandana Singh

September 12, 11:11 AM

Novartis AG (NYSE:NVS) announced the results from two Phase 3 studies (SUNSHINE and SUNRISE) of Cosentyx (secukinumab) in moderate-to-severe hidradenitis suppurativa…

NVS

1 minute read

CMS Says Updated Covid-19 Vaccines Providing Protection Against Omicron Variant Available At No Cost

By Benzinga Newsdesk

September 12, 11:09 AM

- Reuters

AZN

2 minute read

NuCana Presents Data On NUC-7738 At The European Society Of Medical Oncology Annual Meeting 2022

By Benzinga Newsdesk

September 12, 10:57 AM

NUC-7738 Demonstrates Encouraging Anti-Tumor Activity and a Favorable Safety Profile Across a Variety of Solid Tumors NUC-7738 Monotherapy and Combination with Pembrolizumab to be Investigated in Phase 2 PARIS,

NCNA

3 minute read

Natera Presents New Colorectal And Breast Cancer Data From The CIRCULATE-Japan Study At ESMO

By Benzinga Newsdesk

September 12, 9:29 AM

Data from the largest real-world MRD study to date in resectable colorectal cancer reinforces the findings from the recent CIRCULATE-Japan study AUSTIN, Texas, Sept. 12, 2022 /PRNewswire/ -- Natera,

NTRA

3 minute read

Novavax Nuvaxovid COVID-19 Vaccine Granted Expanded Conditional Marketing Authorization In The European Union For Use As A Booster For Adults Aged 18 And Older

By Benzinga Newsdesk

September 12, 9:24 AM

Novavax, Inc. (NASDAQ:NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the European Commission (EC) has

NVAX

1 minute read

Synthetic Biologics Announces Phase I Study To Evaluate The Safety, Tolerability, And Efficacy Of VCN-01 In Combination With Durvalumab In Subjects With Recurrent/ Metastatic Squamous Cell Carcinoma Of The Head And Neck Was Presented At The ESMO Congre…

By Benzinga Newsdesk

September 12, 9:22 AM

Key data and conclusions featured in the Poster Presentation include: · Safety: Treatment with VCN-01 had an acceptable safety profile when administered with durvalumab in the

SYN